![]() |
|
|
2-Adrenergic
Receptor-Gs Complex: Evidence for Agonist-Specific States
Department of Integrative Biology, Pharmacology, and
Physiology, University of Texas-Houston Medical School, Houston,
Texas 77225-0334
A restricted version of the ternary complex model for receptor-G
protein complex formation has recently been proposed. Known as the
two-state model, this model proposes that in the context of agonist and
G protein interactions, only two thermodynamic states exist for the
receptor: active (R*) and inactive (R). One form of this model suggests
that only the R* state of the receptor is capable of interacting with
and subsequently activating G proteins. We directly tested the kinetic
aspects of a strict two-state receptor model in a cell line containing
the native
2-adrenergic receptor that is capable of
inducing Gs expression. We examined adenylyl cyclase
activity in the presence of limiting GTP levels and concluded that
there exists a different rate of heterotrimer dissociation (i.e., HR*G
yields HR* + G*) for different
2-agonists. This finding is inconsistent with a strict two-state model in which R* is a characteristic of the receptor that is independent of the identity of
the agonist. It implies that agonist activation of adenylyl cyclase is
more complicated than a simple two-state model.
This article has been cited by other articles:
![]() |
R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Perez and S. S. Karnik Multiple Signaling States of G-Protein-Coupled Receptors Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Clarke What's for Lunch at the Conformational Cafeteria? Mol. Pharmacol., June 1, 2005; 67(6): 1819 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Simons, S. M. Biggs, A. Waller, T. Foutz, D. F. Cimino, Q. Guo, R. R. Neubig, W.-J. Tang, E. R. Prossnitz, and L. A. Sklar Real-time Analysis of Ternary Complex on Particles: DIRECT EVIDENCE FOR PARTIAL AGONISM AT THE AGONIST-RECEPTOR-G PROTEIN COMPLEX ASSEMBLY STEP OF SIGNAL TRANSDUCTION J. Biol. Chem., April 2, 2004; 279(14): 13514 - 13521. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Tran, J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies Mol. Pharmacol., January 1, 2004; 65(1): 196 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pauwels and F. C. Colpaert Ca2+ Responses in Chinese Hamster Ovary-K1 Cells Demonstrate an Atypical Pattern of Ligand-Induced 5-HT1A Receptor Activation J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Traynor, M. J. Clark, and A. E. Remmers Relationship between Rate and Extent of G Protein Activation: Comparison between Full and Partial Opioid Agonists J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 157 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Port and M. R. Bristow beta -Adrenergic Receptors, Transgenic Mice, and Pharmacological Model Systems Mol. Pharmacol., October 1, 2001; 60(4): 629 - 631. [Full Text] [PDF] |
||||
![]() |
R. Seifert, K. Wenzel-Seifert, U. Gether, and B. K. Kobilka Functional Differences between Full and Partial Agonists: Evidence for Ligand-Specific Receptor Conformations J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1218 - 1226. [Abstract] [Full Text] |
||||
![]() |
C. Watson, G. Chen, P. Irving, J. Way, W.-J. Chen, and T. Kenakin The Use of Stimulus-Biased Assay Systems to Detect Agonist-Specific Receptor Active States: Implications for the Trafficking of Receptor Stimulus by Agonists Mol. Pharmacol., April 13, 2001; 58(6): 1230 - 1238. [Abstract] [Full Text] |
||||
![]() |
M. Waelbroeck Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 2. Testing the "Two-States" Model of Receptor Activation Mol. Pharmacol., April 1, 2001; 59(4): 886 - 893. [Abstract] [Full Text] |
||||
![]() |
T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Wiens, C. S. Nelson, and K. A. Neve Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations Mol. Pharmacol., August 1, 1998; 54(2): 435 - 444. [Abstract] [Full Text] |
||||
![]() |
K. A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W. P. Clarke Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus Mol. Pharmacol., July 1, 1998; 54(1): 94 - 104. [Abstract] [Full Text] |
||||
![]() |
G. Grishina and C. H. Berlot Mutations at the Domain Interface of Gsalpha Impair Receptor-mediated Activation by Altering Receptor and Guanine Nucleotide Binding J. Biol. Chem., June 12, 1998; 273(24): 15053 - 15060. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. January, A. Seibold, B. Whaley, R. W. Hipkin, D. Lin, A. Schonbrunn, R. Barber, and R. B. Clark beta 2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists J. Biol. Chem., September 19, 1997; 272(38): 23871 - 23879. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ghanouni, Z. Gryczynski, J. J. Steenhuis, T. W. Lee, D. L. Farrens, J. R. Lakowicz, and B. K. Kobilka Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the beta 2 Adrenergic Receptor J. Biol. Chem., June 29, 2001; 276(27): 24433 - 24436. [Abstract] [Full Text] [PDF] |
||||